Human papillomaviruses 53 and 66: Clinical aspects and genetic analysis

Virus Research

Volumn 163, Issue 1, 2012, Pages 212-222

  Cento, Valeria ^a   Rahmatalla, Noor ^a   Ciccozzi, Massimo ^b   Presti, Alessandra Lo ^b   Perno, Carlo Federico ^a,c   Ciotti, Marco ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Genetic analysis; HPV 53; HPV 66

Indexed keywords

CAPSID PROTEIN L1; PROTEIN E6; PROTEIN E7;

ADULT; ANTIGENICITY; ARTICLE; CLADISTICS; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS 53; HUMAN PAPILLOMAVIRUS 66; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PHYLOGENY; PRIORITY JOURNAL; UNINDEXED SEQUENCE; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AMINO ACID SUBSTITUTION; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIRULENCE FACTORS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84855600617     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.09.032     Document Type: Article

References (26)

1. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., zur Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal oftaxonomic amendments. Virology 2010, 401:70-79.
2. Bishop B., Dasgupta J., Klein M., Garcea R.L., Christensen N.D., Zhao R., Chen X.S. Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J. Biol. Chem. 2007, 282:31803-31811.
3. Calleja-Macias I.E., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Ortiz-Lopez R., Barrera-Saldaña H.A., Cubie H.A., Cuschieri K., Villa L.L., Bernard H.U. Papillomavirus subtypes are natural and old taxa: phylogeny of the human papillomavirus (HPV) types 44/55 and 68a/b. J. Virol. 2005, 79:6565-6569.
4. Calleja-Macias I.E., Villa L.L., Prado J.C., Kalantari M., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Chu T.Y., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Martins C.R., Sanchez G.I., Bosch F.X., Munoz N., Bernard H.U. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J. Virol. 2005, 79:13630-13640.
5. Cento V., Ciccozzi M., Ronga L., Perno C.F., Ciotti M. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions. J. Med. Virol. 2009, 81:1627-1634.
6. Chen X.S., Garcea R.L., Goldberg I., Casini G., Harrison S.C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 2000, 5:557-567.
7. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
8. De Vuyst H., Steyaert S., Van Renterghem L., Claeys P., Muchiri L., Sitati S., Vansteelandt S., Quint W., Kleter B., Van Marck E., Temmerman M. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex. Transm. Dis. 2003, 30:137-142.
9. Hall T.A. Bioedit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98 NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
10. http://www.who.int/hpvcentre.
11. Huelsenbeck J.P., Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001, 17:754-755.
12. Jameson B.A., Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Cabios 1988, 4:181-186.
13. Kel-Margoulis O.V., Tchekmenev D., Kel A.E., Goessling E., Hornischer K., Lewicki-Potapov B., Wingender E. Composition-sensitive analysis of the human genome for regulatory signals. In Silico Biol. 2003, 3:145-171.
14. Kosakovsky Pond S.L., Frost S.D. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 2005, 22:1208-1222.
15. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., Wolinsky S.M. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989, 7:209-214.
16. Meyer T., Arndt R., Beckmann E.R., Padberg B., Christophers E., Stockfleth E. Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia. Int. J. Gynecol. Cancer 2001, 11:198-204.
17. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
18. Nielsen R., Yang Z. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 1998, 148:929-936.
19. Pastrana D.V., Vass W.C., Lowy D.R., Schiller J.T. NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16. Virology 2001, 279:361-369.
20. Prado J.C., Calleja-Macias I.E., Bernard H.U., Kalantari M., Macay S.A., Allan B., Williamson A.L., Chung L.P., Collins R.J., Zuna R.E., Dunn S.T., Ortiz-Lopez R., Barrera-Saldaña H.A., Cubie H.A., Cuschieri K., von Knebel-Doeberitz M., Sanchez G.I., Bosch F.X., Villa L.L. Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology 2005, 340:95-104.
21. Pond S.L., Frost S.D., Muse S.V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21:676-679.
22. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., Villa L.L. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int. J. Cancer 2007, 120:1763-1768.
23. Svicher V., Gori C., Trignetti M., Visca M., Micheli V., Bernassola M., Salpini R., Gubertini G., Longo R., Niero F., Ceccherini-Silberstein F., De Sanctis G.M., Spanò A., Cappiello G., Perno C.F. The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes. J. Hepatol. 2009, 50:461-470.
24. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, (Epub ahead of print).
25. Wyant P.S., Cerqueira D.M., Moraes D.S., Leite J.P., Martins C.R., de Macedo Brígido M., Raiol T. Phylogeny and polymorphism in the long control region, E6, and L1 of human papillomavirus types 53, 56, and 66 in central Brazil. Int. J. Gynecol. Cancer 2011, 21:222.
26. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., Wheeler C.M. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 1997, 71:2463.